An Effectiveness Trial of the PrEP for WINGS Study

计划入组 307 人 · 首次发布于 2025 年 2 月 28 日

Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)

计划入组 79 人 · 首次发布于 2023 年 11 月 18 日

Pre-Pilot (R61) WINGS+++: mHealth to Improve MOUD Uptake in Women Experiencing Intimate Partner Violence and PTSD

计划入组 7 人 · 首次发布于 2026 年 6 月 24 日

LIFE-001

RSV-001 (Aegis Life)

FOR-001

Wings Therapeutics, Inc.

United States

FAIRY WINGS PTY LTD

Australia

CellMax Life

United States

NervGen Pharma Highlights Clinical Trial Challenges in Spinal Cord Injury at U2FP Symposium

NervGen Nears Enrollment Completion in Spinal Cord Injury Trial of NVG-291

Healx Partners with SCI Ventures in $2M AI-Driven Initiative to Develop Spinal Cord Injury Treatments